Prellis: Prellis Biologics 3D bioprints lymph node to unlock antibody discovery at pace

Biotechnology firm Prellis Biologics has announced the closure of a $14.5 million Series B funding round alongside the creation of a novel antibody discovery platform. Effectively a functioning immune system in a dish, the firm's platform is capable of recreating human cell-to-cell interactions and immune responses, making it ideal for conducting disease therapy R&D. To [...]